A second copy of chromosome 21 results in Trisomy 21, a genetic disorder commonly referred to as Down syndrome. In addition to physical traits like low muscular tone, upward-slanting eyes, and a flat facial profile, this extra genetic material causes intellectual and developmental difficulties. Even though people with Down syndrome may experience a range of health problems, they can lead happy, fulfilling lives if they receive the right support and care. Individual differences in the illness's severity are significant.

There will be a randomized control trial. People with Down syndrome who are five to nine years old will be screened for this study. Adults with Down syndrome and severe ID will not be eligible to participate in this study. Participants will be selected using

Conventional physical therapy will be administered to the participants in both groups. Visual perception interventions will be administered to the intervention group, and then standard treatment will follow. For six weeks, there will be three 45-minute treatment sessions per week. Using outcome measure instruments, data will be gathered twice: once at the beginning of the study and again at the end of the six-week course of treatment.

Inclusion Criteria:

• Age ranged between 6-9 years.
• IQ level mild to moderate (below 40)

Exclusion Criteria:

• Heart,
• GIT problems,
• respiratory problems
• and hearing loss.

single participant will get separate treatment protocols and possible efforts will be put to mask the both group about the treatment.